“As a result of Lewis solely complained of regulatory, quite than fraudulent, violations in his inner communications with AbbVie, the corporate had no purpose to assume Lewis’s issues revolved across the False Claims Act. Extra merely, AbbVie couldn’t have retaliated towards Lewis as a fraud whistleblower as a result of he by no means blew the whistle on fraud, U.S. Courtroom of Appeals for the Seventh Circuit Decide Joshua P. Kolar stated.
Trending
- 5 Ways to Research Key Trends for Your Social Media Ad Campaigns
- Instagram Will Now Enable You to Pin Your Own Post Comments
- Nawazuddin Siddiqui talks about fearing price tags during shopping: ‘Mera itna jee jala, main bata nahi sakta’ | Lifestyle News
- Snapchat Launches First Open Prompt AI Lens
- Threads Rolls Out Auto-Added Threads Counts on Posts
- Amazon VP of Global Video Advertising Krishan Bhatia Exits
- Get 1,800+ Titles Condensed into 12-Minute Micro-Books for Just $40 with Lifetime Access
- Five things everyone should know about weight loss | Health News